Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Hospital 12 de Octubre (17)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  2. Risk factors for poor outcome in adult patients with respiratory syncytial virus infection evaluated at the emergency department

    Journal of Medical Virology, Vol. 96, Núm. 10

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  3. Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience

    Journal of Medical Virology, Vol. 95, Núm. 9

  4. Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 222-235

2022

  1. Current state of antimicrobial stewardship and organ transplantation in Spain

    Transplant Infectious Disease, Vol. 24, Núm. 5

  2. How to manage central venous catheter-related bloodstream infections due to Gram-negative bacilli?

    Current Opinion in Infectious Diseases, Vol. 35, Núm. 6, pp. 583-588

  3. Impact of polymorphisms in genes orchestrating innate immune responses on replication kinetics of Torque teno virus after kidney transplantation

    Frontiers in Genetics, Vol. 13

  4. Long-Term Follow-Up of Patients Diagnosed with COVID-19-Associated Pulmonary Aspergillosis (CAPA)

    Journal of Fungi, Vol. 8, Núm. 8

  5. Non-Tuberculous Mycobacteria and Aspergillus Lung Co-Infection: Systematic Review

    Journal of Clinical Medicine, Vol. 11, Núm. 19

  6. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  7. Pre-emptive approach against toxoplasmosis in allogeneic haematopoietic cell transplantation. Still far away from experience in CMV

    Clinical Microbiology and Infection

  8. Risk Factors and Outcomes for Multidrug Resistant Pseudomonas aeruginosa Infection in Immunocompromised Patients

    Antibiotics, Vol. 11, Núm. 11

  9. Risk of infection in patients with hematological malignancies receiving CAR T-cell therapy: systematic review and meta-analysis

    Expert Review of Anti-Infective Therapy, Vol. 20, Núm. 11, pp. 1455-1476

2021

  1. Intravenous immunoglobulins for the treatment of the hyper-inflammatory response in COVID-19. Another failure of immunomodulatory therapy?

    Clinical Microbiology and Infection

  2. Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination

    PLoS Pathogens, Vol. 17, Núm. 12